You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

Didanosine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for didanosine
US Patents:0
Tradenames:3
Applicants:6
NDAs:9
Drug Master File Entries: 8
Raw Ingredient (Bulk) Api Vendors: 124
Clinical Trials: 155
Patent Applications: 7,345
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in didanosine?didanosine excipients list
DailyMed Link:didanosine at DailyMed
Recent Clinical Trials for didanosine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chang Gung Memorial HospitalPhase 1
TTY BiopharmPhase 1
Intergroupe Francophone de Cancerologie ThoraciquePhase 2

See all didanosine clinical trials

Medical Subject Heading (MeSH) Categories for didanosine
Paragraph IV (Patent) Challenges for DIDANOSINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIDEX Capsules didanosine 75 mg 020155 1 2011-06-06
VIDEX EC Delayed-release Capsules didanosine 200 mg, 250 mg and 400 mg 021183 1 2004-06-01

US Patents and Regulatory Information for didanosine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb VIDEX EC didanosine CAPSULE, DELAYED REL PELLETS;ORAL 021183-001 Oct 31, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma DIDANOSINE didanosine FOR SOLUTION;ORAL 078112-001 Mar 8, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167-002 Dec 3, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb VIDEX EC didanosine CAPSULE, DELAYED REL PELLETS;ORAL 021183-004 Oct 31, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for didanosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-005 Oct 9, 1991 ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-005 Oct 9, 1991 ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-006 Oct 28, 1999 ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991 ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-003 Oct 9, 1991 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.